Publicacións en colaboración con investigadores/as de McGill University (10)

2024

  1. Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen-Glucose Deprivation

    ACS Pharmacology and Translational Science, Vol. 7, Núm. 3, pp. 680-692

  2. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  4. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. New approaches in nanomedicine for ischemic stroke

    Pharmaceutics, Vol. 13, Núm. 5

2013

  1. Identification of three new cis-regulatory IRF5 polymorphisms: In vitro studies

    Arthritis Research and Therapy, Vol. 15, Núm. 4

2011

  1. Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: Analysis of multiple experiments with lymphoblastoid cell lines

    Arthritis Research and Therapy, Vol. 13, Núm. 3